Sonia Garcia

TMS is not shock therapy. That is the first thing to settle in any TMS vs ECT comparison, because that phrase, and all the baggage that comes with it, refers to electroconvulsive therapy (ECT), not transcranial magnetic stimulation. TMS uses magnetic pulses, involves no anesthesia and no seizure, and you drive yourself home afterward. Both are evidence-based brain stimulation treatments for depression, and both work. They differ substantially in how they work, what the treatment is like to go through, and who they are typically used for. Knowing the difference between TMS and ECT is what lets you and your psychiatrist match the treatment to the situation.

What Is TMS?

Transcranial magnetic stimulation delivers focused magnetic pulses through a coil resting on the scalp to a specific region of the brain, usually the left dorsolateral prefrontal cortex, which is involved in mood regulation. The stimulation is targeted to that one site rather than generalized across the brain, and because it stimulates a small area without inducing a seizure, the procedure needs no anesthesia and takes place in an ordinary clinic or office, as the National Institute of Mental Health describes. FDA clearance came in 2008 for major depressive disorder, with obsessive-compulsive disorder added in 2018.

‍

At our clinics, a standard course of TMS therapy is 20 to 30 sessions, one per weekday, 30 to 40 minutes each, over about four to six weeks, and you sit awake in a chair for every one of them. No seizure is induced, nothing enters your bloodstream, and when the session ends you can drive yourself home and return to your day.

What Is ECT?

Electroconvulsive therapy is a controlled medical procedure performed under general anesthesia. You are given a short-acting anesthetic and an intravenous muscle relaxant to prevent movement, and electrodes on the scalp deliver a brief electrical current that produces seizure activity in the brain lasting under a minute. You wake within minutes, recover over the following hour or so, and need someone to take you home. A typical course is three sessions a week until symptoms improve, usually within 6 to 12 treatments.

‍

ECT is one of the oldest treatments in psychiatry and one of the most effective for severe depression. The FDA's clearance covers catatonia and severe depressive episodes in people age 13 and older with major depression or bipolar disorder who have not responded to other treatments or need a rapid response, and it is also used for mania and for certain presentations of schizophrenia and schizoaffective disorder. It is most often reserved for situations where fast, powerful relief matters: acute suicidality, depression with psychotic features, or catatonia.

‍

The stigma around ECT comes from portrayals that are decades out of date, from an era before anesthesia and muscle relaxants were used. Modern ECT is delivered in a monitored setting by a full medical team, and its main drawback is not what those old images suggest. It is the effect on memory, covered below.

TMS vs ECT: Side-by-Side Comparison

Effectiveness: What the Research Shows

Both treatments work. In head-to-head trials of electroconvulsive therapy vs TMS, ECT comes out ahead. A 2014 systematic review and meta-analysis in Depression Research and Treatment pooled nine randomized clinical trials comparing the two, with 384 participants in total. Both groups improved significantly. On the Hamilton Depression Rating Scale, the standard clinician-rated measure, scores fell by an average of 15.4 points with ECT and 9.3 points with TMS, a statistically significant difference (P = 0.011). The author concluded that ECT produced larger reductions in depressive symptoms, while the results also supported the therapeutic validity of TMS for people with treatment-resistant depression.

‍

A few things keep that finding in proportion. The trials were conducted between 2000 and 2011, largely with early TMS protocols. And "more effective" is not the same as "the right choice." Real-world TMS outcomes come from a different population. In naturalistic data from 42 U.S. clinics, 58% of outpatients with medication-resistant depression responded to a standard course and 37% reached remission. For someone whose depression has resisted medication but who is stable enough for outpatient care, that is the relevant number.

‍

In the head-to-head studies that exist, ECT delivers stronger short-term symptom reduction. TMS delivers a meaningful effect without anesthesia, without a hospital, and without the recovery and memory considerations described next.

Side Effects and Memory Concerns

Memory is the question people bring to this comparison more than any other, and it deserves a direct answer.

‍

ECT is associated with memory effects, particularly for events around the time of treatment. NIMH describes memory loss close to the treatment period that is sometimes more severe but usually improves over the days and weeks after the course ends, alongside headaches, upset stomach, muscle aches, and short-lived confusion. The largest analysis of the question, a 2010 meta-analysis in Biological Psychiatry covering 84 studies and 2,981 patients, found that measurable cognitive effects were mainly limited to the first three days after treatment. By 4 to 15 days, nearly all measures had recovered, and after 15 days processing speed, working memory, new learning, and some aspects of executive function had improved beyond where they were before treatment, most likely because the depression itself had lifted. Some people do report longer-lasting gaps in personal memories from the months around treatment, and that possibility belongs in the conversation before ECT.

‍

TMS carries no known negative effect on memory or thinking, and it requires no anesthesia. Its side effects are local: discomfort where the coil sits, tingling or twitching of scalp or facial muscles during the pulses, mild headache, and occasional brief lightheadedness. Those usually fade within the first week. Seizure is the one serious risk, and it is exceedingly rare. Screening for seizure history, metal in the head, and implanted devices is what keeps it that way.

What to Expect: The Treatment Experience

The daily reality of the two treatments could not be more different.

‍

A TMS session is a 30-to-40-minute appointment. You sit in a chair, awake, while the coil delivers pulses that feel like tapping on the scalp. When it ends, you stand up, get in your car, and go on with your day, then repeat tomorrow. There is no downtime and no preparation beyond an initial screening visit.

‍

An ECT session is a medical procedure. You fast beforehand, an IV is placed, and you are under anesthesia for a few minutes while the treatment is delivered in a hospital or specialized clinic with an anesthesia provider and a psychiatrist present. You wake up groggy, spend time in recovery, and need someone to take you home. Over several sessions a week for several weeks, that is a real commitment from you and whoever supports you, and ECT is sometimes delivered during an inpatient stay rather than as an outpatient.

Who Is Each Treatment Typically Recommended For?

These are different tools for different clinical pictures, not simply a better and a worse option.

‍

ECT is typically recommended when depression is severe, acute, or urgent, and the speed of response matters: someone at high risk of suicide, someone with psychotic depression, someone with catatonia, or someone who has not responded to multiple treatments. The trade-off of anesthesia and memory effects is accepted because the alternative is worse, and for anyone in that situation care for suicidal thoughts comes first.

‍

TMS is typically recommended for moderate or treatment-resistant depression in someone who is stable enough for outpatient care and can attend daily sessions, when there is no need for the fastest possible response. It is often the next step after antidepressants have failed and before ECT would be considered. For that person, a treatment without anesthesia, without memory effects, and without disruption to work or family life has real value, even if its average effect size is smaller.

Talking to a Psychiatrist About Your Options

Choosing between TMS and ECT is a clinical decision, made with a psychiatrist, that turns on three things: how severe your depression is, how urgently it needs to change, and what you have already tried. It is not a decision to make from a comparison table alone, including this one.

‍

At Amae, we offer TMS at our Los Angeles, Los Altos, and San Mateo clinics as part of our integrated outpatient clinics, where psychiatry, therapy, primary care, and peer support come from one team. We do not offer ECT. If our psychiatrists conclude that ECT is the better clinical fit for you, they will say so and help coordinate a referral, because the goal is the right treatment, not the treatment we happen to provide. If you are trying to work out where you stand, talk with an Amae psychiatrist. And if you are having thoughts of suicide right now, call or text 988, the Suicide and Crisis Lifeline.

Frequently Asked Questions

Is TMS the same as ECT?

No, and it is not "shock therapy" either. That phrase refers to ECT. TMS uses magnetic pulses targeted to one region of the brain, with no anesthesia and no seizure, and you stay awake and drive yourself home. ECT uses electrical stimulation to produce a brief, controlled seizure under general anesthesia in a monitored medical setting.

Does TMS cause memory loss like ECT can?

No. TMS has no known negative effect on memory or thinking; its side effects are scalp discomfort and headache, both short-lived and usually gone within a week. ECT can cause memory loss around the time of treatment that typically improves over the weeks after the course ends.

Which is more effective, TMS or ECT?

In head-to-head research, ECT produces larger short-term symptom reductions. A 2014 meta-analysis of nine randomized trials found average Hamilton scale drops of 15.4 points with ECT versus 9.3 with TMS, with both treatments producing significant improvement. TMS remains a well-supported outpatient option without anesthesia or recovery time, so "more effective" is not the same as "right for your situation."

Is ECT still used today?

Yes. ECT remains a well-established, evidence-based treatment, typically used for severe, urgent, psychotic, or catatonic depression and for depression that has not responded to other treatments. The stigma around it comes from decades-old portrayals that do not resemble modern practice.

Can you drive yourself home after TMS or ECT?

After TMS, yes. There is no anesthesia or sedation, so people typically drive themselves home and return to their day immediately. After ECT, no. General anesthesia means you need a support person to take you home and some recovery time before normal activities.

Does Amae Health offer ECT?

No. We offer TMS at our Los Angeles, Los Altos, and San Mateo clinics as part of integrated psychiatric care. We do not offer ECT, and if a psychiatrist concludes that ECT is the better fit for your situation, we help coordinate a referral to a provider who does.

‍

Citations

1. Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depression Research and Treatment. 2014. https://pubmed.ncbi.nlm.nih.gov/25143831/ (Tier 1)
2. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
3. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry. 2010. https://pubmed.ncbi.nlm.nih.gov/20673880/ (Tier 1)
4. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
5. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍

Metabolic psychiatry is an emerging field that examines how metabolic dysfunction (insulin resistance, mitochondrial problems, and chronic inflammation) affects brain function.Rather than treating symptoms alone, it looks at the metabolic factors that may underlie conditions such as depression, bipolar disorder, and schizophrenia. The interest is strongest in complex mental illness, where standard treatment often falls short and where physical and psychiatric problems tend to travel together. This article explains the science behind the field, the therapies it uses, the evidence so far, and who researchers think it may help, along with the honest limits of what is still an early area of study.

What Is Metabolic Psychiatry?

Metabolic psychiatry views serious mental illnesses not solely as chemical imbalances or psychological phenomena, but as conditions also connected to disruptions in brain energy metabolism, inflammation, and cellular health. It does not discard the standard understanding of psychiatric illness. It adds a layer, asking whether the way the brain produces and uses energy is part of the picture.

‍

The term was introduced in 2015 by Dr. Shebani Sethi, who founded the first academic metabolic psychiatry clinic and research program at Stanford University after noticing how often her patients with treatment-resistant psychiatric conditions also had metabolic problems. The approach builds on more than a century of ketogenic-therapy research in neurology, where the ketogenic diet has long been used to treat drug-resistant epilepsy. Metabolic psychiatry is still emerging, and reputable clinicians frame it as a promising area of research rather than a finished or proven model of care.

The Link Between Metabolism and Mental Health

The brain is an energy-hungry organ. It makes up about 2% of body weight but uses roughly 20% of the body's energy, and it depends on a steady fuel supply to function. When metabolism breaks down, through insulin resistance, unstable blood sugar, or chronic inflammation, the brain can struggle to access the energy it needs, and researchers believe this may contribute to psychiatric symptoms.

‍

The connection runs in both directions. Roughly a third of people with schizophrenia or bipolar disorder also have metabolic syndrome, a cluster of conditions including high blood sugar, high blood pressure, and abnormal cholesterol (Vancampfort et al., World Psychiatry, 2015). People living with serious mental illness carry roughly 1.5 to 2 times the risk of metabolic syndrome and type 2 diabetes compared with the general population, an elevation driven partly by the illness, partly by medication side effects, and partly by shared biology. This is an association, not proven causation. But it is strong and consistent enough that the field takes it seriously.

How Does Metabolic Psychiatry Work?

The central idea, articulated most fully in Dr. Chris Palmer's Brain Energy theory, is that many mental disorders may be, in part, metabolic disorders of the brain. Palmer, a psychiatrist at McLean Hospital and Harvard Medical School, places mitochondria, the structures that produce energy inside cells, at the center of the model.

‍

Here is the mechanism in plain terms. When brain cells cannot get or use energy properly, often because insulin resistance blocks glucose from entering cells, it can trigger a cascade: mitochondrial dysfunction, oxidative stress, and inflammation. That cascade can disrupt neurotransmitters and interfere with the brain regions that regulate mood, thinking, and perception. Metabolic therapies aim to work upstream of that cascade, restoring the brain's energy supply and lowering inflammation rather than only adjusting neurotransmitters downstream. The theory is compelling and biologically plausible, and it remains a theory under active investigation, not settled fact.

Metabolic Therapies Used in Metabolic Psychiatry

One point clinicians in this field stress is that the toolkit is broader than a single diet. Metabolic health is shaped by many inputs, and a metabolic approach typically addresses several at once:

‍

• Ketogenic therapy: the clinically supervised use of a well-formulated ketogenic diet to shift the brain toward ketones as fuel (the cornerstone intervention, covered below).
• Nutritional changes: reducing sugar, ultra-processed foods, and refined carbohydrates.
• Intermittent fasting: may improve insulin sensitivity and reduce inflammation.
• Exercise: improves insulin sensitivity, supports mitochondrial function, and reduces inflammation.
• Sleep optimization: poor sleep worsens insulin resistance and mitochondrial function.
• Stress management: chronic stress raises cortisol, which disrupts glucose regulation.
• Removing metabolic stressors: reducing smoking, excess alcohol, and sedentary time.

‍

Several of these are ordinary lifestyle measures. What is different in metabolic psychiatry is the reason behind them: they are used deliberately to improve brain energy metabolism, tracked with lab data, and coordinated with conventional psychiatric care.

Ketogenic Therapy: The Cornerstone Intervention

The ketogenic diet was developed more than a century ago to treat drug-resistant epilepsy, and that long neurological track record is part of why it draws the most research attention in psychiatry. A ketogenic diet is very low in carbohydrates, which shifts the body into nutritional ketosis: the liver begins converting fat into ketones, an alternate fuel the brain can use when insulin resistance limits its access to glucose.

‍

Beyond supplying fuel, ketones may reduce inflammation, lower oxidative stress, support mitochondrial function, and help rebalance neurotransmitters. Those are plausible mechanisms, and they are still being studied.

‍

The most important thing to understand is that ketogenic therapy, as used in this field, is a clinical intervention, not a do-it-yourself diet. It is supervised by clinicians, monitored with regular lab work, and integrated with a person's other treatment. It is not presented by responsible practitioners as a cure, and it is not a replacement for medication. Any change to psychiatric medication belongs in the hands of a treating clinician who knows the person's history.

What Does a Metabolic Psychiatry Evaluation Involve?

A metabolic approach usually starts with screening that goes beyond a standard psychiatric assessment, adding blood work to build a picture of a person's metabolic health. That panel commonly includes:

‍

• Fasting glucose and insulin, plus hemoglobin A1C, to assess blood sugar regulation
• A lipid panel: triglycerides, HDL, and LDL
• A thyroid panel
• Inflammatory markers such as C-reactive protein (CRP)
• Key vitamin and mineral levels, including B12, folate, magnesium, and omega-3s

‍

The point of this data is not to produce a standalone diagnosis. It is to identify metabolic factors a clinician can address alongside conventional psychiatric care, and to establish a baseline that lab work can track over time.

Metabolic Psychiatry vs. Standard Psychiatry

Metabolic psychiatry is best understood as a complement to standard psychiatric care, not a replacement for it.

‍

‍

The honest framing matters. Standard psychiatry, medication and therapy, remains the evidence-based foundation. Metabolic psychiatry adds a layer that some clinicians and researchers believe addresses root-cause biology, and it works best woven into conventional treatment rather than substituted for it.

How Metabolic Psychiatry Fits Within Precision Psychiatry

Metabolic psychiatry is often considered part of the broader precision psychiatry movement, which tailors treatment to each person's unique biology rather than applying population averages. Both reject one-size-fits-all, trial-and-error prescribing in favor of care informed by an individual's own data. Metabolic screening is one example of that data. Precision psychiatry is the larger shift, and it is the philosophy behind research programs like the Amae Institute, which studies how to match people living with complex conditions to more effective, individualized care.

Who Might Benefit from Metabolic Psychiatry?

Research and clinical interest are concentrated in complex mental health conditions, the situations where standard treatment most often falls short. The strongest focus so far has been on:

‍

• Bipolar disorder and schizophrenia, where metabolic syndrome is common and where the first clinical trials have concentrated. People navigating a recent diagnosis can learn more about bipolar disorder treatment and how it is managed within an integrated model.
• Treatment-resistant depression, where conventional approaches have not produced adequate relief.
• People with co-occurring metabolic conditions such as insulin resistance, type 2 diabetes, or obesity.
• People who have not responded well to, or cannot tolerate, standard treatments.

‍

Two caveats belong with every one of these. The field is emerging, so the evidence is still being built. And metabolic therapies are used alongside, not instead of, conventional psychiatric care, always under medical supervision. Whether a metabolic approach is appropriate for any individual is a clinical judgment, made by a clinician who knows that person's full history.

The Evidence So Far

The evidence is a mix of a strong foundation and promising but early results. Ketogenic therapy has more than a century of established use in epilepsy, which gives the underlying biology real credibility. For psychiatric conditions specifically, the picture is younger.

‍

In 2024, a Stanford pilot trial led by Dr. Sethi followed more than 20 adults with bipolar disorder or schizophrenia who also had metabolic abnormalities through a four-month ketogenic intervention. It was the first U.S. clinical trial of a ketogenic diet for serious mental illness since 1965. Most participants showed improvement in their psychiatric symptoms, reduced medication-related weight gain, and better metabolic markers; by the study's end, none still met the criteria for metabolic syndrome (Sethi et al., Psychiatry Research, 2024). It was a small, single-arm pilot, not a randomized controlled trial, so the results are encouraging rather than definitive.

‍

Alongside trials like this, case series and clinical reports describe stabilized mood and, in some cases, reduced reliance on medication under supervision. Larger, more rigorous randomized trials are now underway (Nature Mental Health, 2026). The honest summary: a solid mechanistic foundation, genuinely promising early psychiatric results, and a field that still needs bigger and better-controlled studies before anyone can call it established.

A Whole-Person Approach at Amae Health

The logic underneath metabolic psychiatry, that physical and mental health are not separate systems, is the same logic behind integrated care. At Amae Health, primary care physicians and registered dietitians are part of the psychiatric care team, so physical health, nutrition, sleep, and metabolic comorbidities are treated alongside mental health rather than as an afterthought. That is not the same as offering a specific metabolic-psychiatry program, but it reflects the same whole-person, precision-oriented conviction: complex conditions deserve care that looks at the whole biology of a person.

‍

If you or someone you love is living with a complex mental health condition, our care model and resources for patients and families explain how integrated treatment works. To ask about care, reach out to our team.

‍

If you are in crisis or thinking about suicide, call or text the 988 Suicide and Crisis Lifeline at 988 for free, confidential support, available 24/7.

Frequently Asked Questions

What is metabolic psychiatry?

Metabolic psychiatry is an emerging field that addresses metabolic dysfunction, such as insulin resistance, mitochondrial problems, and inflammation, that may affect brain function and mental health. It targets underlying metabolic factors alongside, not instead of, conventional psychiatric care.

‍

How does metabolic psychiatry work?

The brain depends on a steady energy supply. When metabolism is disrupted, often through insulin resistance that keeps cells from using glucose, the brain can struggle to access fuel, which researchers believe may worsen psychiatric symptoms. Metabolic therapies aim to restore that brain energy and reduce inflammation, working upstream of the neurotransmitter changes that standard treatment targets.

‍

What is ketogenic therapy for mental health?

It is the clinically supervised use of a well-formulated ketogenic diet to shift the brain toward ketones as fuel. Originally developed for epilepsy, it is the most-studied metabolic therapy for serious mental illness. It is used under medical supervision with regular lab monitoring, not as a do-it-yourself diet.

‍

Is metabolic psychiatry evidence-based?

Ketogenic therapy has strong evidence in epilepsy. For psychiatric conditions, the evidence is emerging: promising pilot studies and the early stages of larger trials, but still preliminary. It is used alongside conventional care, not in place of it.

‍

Can metabolic psychiatry replace medication?

No. It is designed to complement conventional psychiatric care, not replace it. Some people reduce their reliance on medication under close medical supervision, but changing psychiatric medication should never be attempted alone.

‍

Who is metabolic psychiatry best for?

Research has focused most on bipolar disorder, schizophrenia, and treatment-resistant depression, especially alongside co-occurring metabolic conditions. A clinician who knows the person's history determines whether a metabolic approach is appropriate. Support is available, and no one should navigate a serious condition alone.

‍

Citations

1. Vancampfort D, Stubbs B, Mitchell AJ, et al. "Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis." World Psychiatry, 2015. PubMed 26407790. Tier 1 (peer-reviewed meta-analysis).
2. Sethi S, Wakeham D, Ketter T, et al. "Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial." Psychiatry Research, 2024. PubMed 38547601. Tier 1 (peer-reviewed pilot trial).
3. "Metabolic psychiatry targeting metabolic dysregulation in mental health." Nature Mental Health, 2026. nature.com. Tier 1 (peer-reviewed review).

‍

Further reading (external resources): Stanford Metabolic Psychiatry (Dr. Shebani Sethi); Metabolic Mind (Baszucki Group).

‍

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍